img

Global Parenteral Dosage Form Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Parenteral Dosage Form Market Insights, Forecast to 2034

Global Parenteral Dosage Form market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Parenteral Dosage Form industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
According to the Global Use of Medicines 2024 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
Global Use of Medicines 2024 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.
Report Covers
This report presents an overview of global Parenteral Dosage Form market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Parenteral Dosage Form market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Ashland
Tepnel Pharma Services
Ascendia Pharmaceuticals
Thermo Fisher Scientific
ProJect Pharmaceutics
Lonza
BOC Sciences
Segment by Type
Emulsions for Injection
Powders for Injection
Gels for Injection

Segment by Application


Hospital
Clinic
Others

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Parenteral Dosage Form plant distribution, commercial date of Parenteral Dosage Form, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Parenteral Dosage Form introduction, etc. Parenteral Dosage Form Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Parenteral Dosage Form
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Parenteral Dosage Form Product Introduction
1.2 Market by Type
1.2.1 Global Parenteral Dosage Form Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Emulsions for Injection
1.2.3 Powders for Injection
1.2.4 Gels for Injection
1.3 Market by Application
1.3.1 Global Parenteral Dosage Form Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Parenteral Dosage Form Sales Estimates and Forecasts 2018-2029
2.2 Global Parenteral Dosage Form Revenue by Region
2.2.1 Global Parenteral Dosage Form Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Parenteral Dosage Form Revenue by Region (2018-2024)
2.2.3 Global Parenteral Dosage Form Revenue by Region (2024-2029)
2.2.4 Global Parenteral Dosage Form Revenue Market Share by Region (2018-2029)
2.3 Global Parenteral Dosage Form Sales Estimates and Forecasts 2018-2029
2.4 Global Parenteral Dosage Form Sales by Region
2.4.1 Global Parenteral Dosage Form Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Parenteral Dosage Form Sales by Region (2018-2024)
2.4.3 Global Parenteral Dosage Form Sales by Region (2024-2029)
2.4.4 Global Parenteral Dosage Form Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Parenteral Dosage Form Sales by Manufacturers
3.1.1 Global Parenteral Dosage Form Sales by Manufacturers (2018-2024)
3.1.2 Global Parenteral Dosage Form Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Parenteral Dosage Form in 2022
3.2 Global Parenteral Dosage Form Revenue by Manufacturers
3.2.1 Global Parenteral Dosage Form Revenue by Manufacturers (2018-2024)
3.2.2 Global Parenteral Dosage Form Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Parenteral Dosage Form Revenue in 2022
3.3 Global Key Players of Parenteral Dosage Form, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Parenteral Dosage Form Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Parenteral Dosage Form Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Parenteral Dosage Form, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Parenteral Dosage Form, Product Offered and Application
3.8 Global Key Manufacturers of Parenteral Dosage Form, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Parenteral Dosage Form Sales by Type
4.1.1 Global Parenteral Dosage Form Historical Sales by Type (2018-2024)
4.1.2 Global Parenteral Dosage Form Forecasted Sales by Type (2024-2029)
4.1.3 Global Parenteral Dosage Form Sales Market Share by Type (2018-2029)
4.2 Global Parenteral Dosage Form Revenue by Type
4.2.1 Global Parenteral Dosage Form Historical Revenue by Type (2018-2024)
4.2.2 Global Parenteral Dosage Form Forecasted Revenue by Type (2024-2029)
4.2.3 Global Parenteral Dosage Form Revenue Market Share by Type (2018-2029)
4.3 Global Parenteral Dosage Form Price by Type
4.3.1 Global Parenteral Dosage Form Price by Type (2018-2024)
4.3.2 Global Parenteral Dosage Form Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Parenteral Dosage Form Sales by Application
5.1.1 Global Parenteral Dosage Form Historical Sales by Application (2018-2024)
5.1.2 Global Parenteral Dosage Form Forecasted Sales by Application (2024-2029)
5.1.3 Global Parenteral Dosage Form Sales Market Share by Application (2018-2029)
5.2 Global Parenteral Dosage Form Revenue by Application
5.2.1 Global Parenteral Dosage Form Historical Revenue by Application (2018-2024)
5.2.2 Global Parenteral Dosage Form Forecasted Revenue by Application (2024-2029)
5.2.3 Global Parenteral Dosage Form Revenue Market Share by Application (2018-2029)
5.3 Global Parenteral Dosage Form Price by Application
5.3.1 Global Parenteral Dosage Form Price by Application (2018-2024)
5.3.2 Global Parenteral Dosage Form Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Parenteral Dosage Form Market Size by Type
6.1.1 US & Canada Parenteral Dosage Form Sales by Type (2018-2029)
6.1.2 US & Canada Parenteral Dosage Form Revenue by Type (2018-2029)
6.2 US & Canada Parenteral Dosage Form Market Size by Application
6.2.1 US & Canada Parenteral Dosage Form Sales by Application (2018-2029)
6.2.2 US & Canada Parenteral Dosage Form Revenue by Application (2018-2029)
6.3 US & Canada Parenteral Dosage Form Market Size by Country
6.3.1 US & Canada Parenteral Dosage Form Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Parenteral Dosage Form Sales by Country (2018-2029)
6.3.3 US & Canada Parenteral Dosage Form Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Parenteral Dosage Form Market Size by Type
7.1.1 Europe Parenteral Dosage Form Sales by Type (2018-2029)
7.1.2 Europe Parenteral Dosage Form Revenue by Type (2018-2029)
7.2 Europe Parenteral Dosage Form Market Size by Application
7.2.1 Europe Parenteral Dosage Form Sales by Application (2018-2029)
7.2.2 Europe Parenteral Dosage Form Revenue by Application (2018-2029)
7.3 Europe Parenteral Dosage Form Market Size by Country
7.3.1 Europe Parenteral Dosage Form Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Parenteral Dosage Form Sales by Country (2018-2029)
7.3.3 Europe Parenteral Dosage Form Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Parenteral Dosage Form Market Size
8.1.1 China Parenteral Dosage Form Sales (2018-2029)
8.1.2 China Parenteral Dosage Form Revenue (2018-2029)
8.2 China Parenteral Dosage Form Market Size by Application
8.2.1 China Parenteral Dosage Form Sales by Application (2018-2029)
8.2.2 China Parenteral Dosage Form Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Parenteral Dosage Form Market Size by Type
9.1.1 Asia Parenteral Dosage Form Sales by Type (2018-2029)
9.1.2 Asia Parenteral Dosage Form Revenue by Type (2018-2029)
9.2 Asia Parenteral Dosage Form Market Size by Application
9.2.1 Asia Parenteral Dosage Form Sales by Application (2018-2029)
9.2.2 Asia Parenteral Dosage Form Revenue by Application (2018-2029)
9.3 Asia Parenteral Dosage Form Sales by Region
9.3.1 Asia Parenteral Dosage Form Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Parenteral Dosage Form Revenue by Region (2018-2029)
9.3.3 Asia Parenteral Dosage Form Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Parenteral Dosage Form Market Size by Type
10.1.1 Middle East, Africa and Latin America Parenteral Dosage Form Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Parenteral Dosage Form Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Parenteral Dosage Form Market Size by Application
10.2.1 Middle East, Africa and Latin America Parenteral Dosage Form Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Parenteral Dosage Form Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Parenteral Dosage Form Sales by Country
10.3.1 Middle East, Africa and Latin America Parenteral Dosage Form Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Parenteral Dosage Form Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Parenteral Dosage Form Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Ashland
11.1.1 Ashland Company Information
11.1.2 Ashland Overview
11.1.3 Ashland Parenteral Dosage Form Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Ashland Parenteral Dosage Form Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Ashland Recent Developments
11.2 Tepnel Pharma Services
11.2.1 Tepnel Pharma Services Company Information
11.2.2 Tepnel Pharma Services Overview
11.2.3 Tepnel Pharma Services Parenteral Dosage Form Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Tepnel Pharma Services Parenteral Dosage Form Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Tepnel Pharma Services Recent Developments
11.3 Ascendia Pharmaceuticals
11.3.1 Ascendia Pharmaceuticals Company Information
11.3.2 Ascendia Pharmaceuticals Overview
11.3.3 Ascendia Pharmaceuticals Parenteral Dosage Form Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Ascendia Pharmaceuticals Parenteral Dosage Form Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Ascendia Pharmaceuticals Recent Developments
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Information
11.4.2 Thermo Fisher Scientific Overview
11.4.3 Thermo Fisher Scientific Parenteral Dosage Form Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Thermo Fisher Scientific Parenteral Dosage Form Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Thermo Fisher Scientific Recent Developments
11.5 ProJect Pharmaceutics
11.5.1 ProJect Pharmaceutics Company Information
11.5.2 ProJect Pharmaceutics Overview
11.5.3 ProJect Pharmaceutics Parenteral Dosage Form Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 ProJect Pharmaceutics Parenteral Dosage Form Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 ProJect Pharmaceutics Recent Developments
11.6 Lonza
11.6.1 Lonza Company Information
11.6.2 Lonza Overview
11.6.3 Lonza Parenteral Dosage Form Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Lonza Parenteral Dosage Form Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Lonza Recent Developments
11.7 BOC Sciences
11.7.1 BOC Sciences Company Information
11.7.2 BOC Sciences Overview
11.7.3 BOC Sciences Parenteral Dosage Form Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 BOC Sciences Parenteral Dosage Form Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 BOC Sciences Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Parenteral Dosage Form Industry Chain Analysis
12.2 Parenteral Dosage Form Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Parenteral Dosage Form Production Mode & Process
12.4 Parenteral Dosage Form Sales and Marketing
12.4.1 Parenteral Dosage Form Sales Channels
12.4.2 Parenteral Dosage Form Distributors
12.5 Parenteral Dosage Form Customers
13 Market Dynamics
13.1 Parenteral Dosage Form Industry Trends
13.2 Parenteral Dosage Form Market Drivers
13.3 Parenteral Dosage Form Market Challenges
13.4 Parenteral Dosage Form Market Restraints
14 Key Findings in The Global Parenteral Dosage Form Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Parenteral Dosage Form Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Emulsions for Injection
Table 3. Major Manufacturers of Powders for Injection
Table 4. Major Manufacturers of Gels for Injection
Table 5. Global Parenteral Dosage Form Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Parenteral Dosage Form Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Parenteral Dosage Form Revenue by Region (2018-2024) & (US$ Million)
Table 8. Global Parenteral Dosage Form Revenue by Region (2024-2029) & (US$ Million)
Table 9. Global Parenteral Dosage Form Revenue Market Share by Region (2018-2024)
Table 10. Global Parenteral Dosage Form Revenue Market Share by Region (2024-2029)
Table 11. Global Parenteral Dosage Form Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 12. Global Parenteral Dosage Form Sales by Region (2018-2024) & (Kiloton)
Table 13. Global Parenteral Dosage Form Sales by Region (2024-2029) & (Kiloton)
Table 14. Global Parenteral Dosage Form Sales Market Share by Region (2018-2024)
Table 15. Global Parenteral Dosage Form Sales Market Share by Region (2024-2029)
Table 16. Global Parenteral Dosage Form Sales by Manufacturers (2018-2024) & (Kiloton)
Table 17. Global Parenteral Dosage Form Sales Share by Manufacturers (2018-2024)
Table 18. Global Parenteral Dosage Form Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 19. Global Parenteral Dosage Form Revenue Share by Manufacturers (2018-2024)
Table 20. Global Key Players of Parenteral Dosage Form, Industry Ranking, 2021 VS 2022 VS 2024
Table 21. Parenteral Dosage Form Price by Manufacturers 2018-2024 (US$/Ton)
Table 22. Global Parenteral Dosage Form Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Parenteral Dosage Form by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parenteral Dosage Form as of 2022)
Table 24. Global Key Manufacturers of Parenteral Dosage Form, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of Parenteral Dosage Form, Product Offered and Application
Table 26. Global Key Manufacturers of Parenteral Dosage Form, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Parenteral Dosage Form Sales by Type (2018-2024) & (Kiloton)
Table 29. Global Parenteral Dosage Form Sales by Type (2024-2029) & (Kiloton)
Table 30. Global Parenteral Dosage Form Sales Share by Type (2018-2024)
Table 31. Global Parenteral Dosage Form Sales Share by Type (2024-2029)
Table 32. Global Parenteral Dosage Form Revenue by Type (2018-2024) & (US$ Million)
Table 33. Global Parenteral Dosage Form Revenue by Type (2024-2029) & (US$ Million)
Table 34. Global Parenteral Dosage Form Revenue Share by Type (2018-2024)
Table 35. Global Parenteral Dosage Form Revenue Share by Type (2024-2029)
Table 36. Parenteral Dosage Form Price by Type (2018-2024) & (US$/Ton)
Table 37. Global Parenteral Dosage Form Price Forecast by Type (2024-2029) & (US$/Ton)
Table 38. Global Parenteral Dosage Form Sales by Application (2018-2024) & (Kiloton)
Table 39. Global Parenteral Dosage Form Sales by Application (2024-2029) & (Kiloton)
Table 40. Global Parenteral Dosage Form Sales Share by Application (2018-2024)
Table 41. Global Parenteral Dosage Form Sales Share by Application (2024-2029)
Table 42. Global Parenteral Dosage Form Revenue by Application (2018-2024) & (US$ Million)
Table 43. Global Parenteral Dosage Form Revenue by Application (2024-2029) & (US$ Million)
Table 44. Global Parenteral Dosage Form Revenue Share by Application (2018-2024)
Table 45. Global Parenteral Dosage Form Revenue Share by Application (2024-2029)
Table 46. Parenteral Dosage Form Price by Application (2018-2024) & (US$/Ton)
Table 47. Global Parenteral Dosage Form Price Forecast by Application (2024-2029) & (US$/Ton)
Table 48. US & Canada Parenteral Dosage Form Sales by Type (2018-2024) & (Kiloton)
Table 49. US & Canada Parenteral Dosage Form Sales by Type (2024-2029) & (Kiloton)
Table 50. US & Canada Parenteral Dosage Form Revenue by Type (2018-2024) & (US$ Million)
Table 51. US & Canada Parenteral Dosage Form Revenue by Type (2024-2029) & (US$ Million)
Table 52. US & Canada Parenteral Dosage Form Sales by Application (2018-2024) & (Kiloton)
Table 53. US & Canada Parenteral Dosage Form Sales by Application (2024-2029) & (Kiloton)
Table 54. US & Canada Parenteral Dosage Form Revenue by Application (2018-2024) & (US$ Million)
Table 55. US & Canada Parenteral Dosage Form Revenue by Application (2024-2029) & (US$ Million)
Table 56. US & Canada Parenteral Dosage Form Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 57. US & Canada Parenteral Dosage Form Revenue by Country (2018-2024) & (US$ Million)
Table 58. US & Canada Parenteral Dosage Form Revenue by Country (2024-2029) & (US$ Million)
Table 59. US & Canada Parenteral Dosage Form Sales by Country (2018-2024) & (Kiloton)
Table 60. US & Canada Parenteral Dosage Form Sales by Country (2024-2029) & (Kiloton)
Table 61. Europe Parenteral Dosage Form Sales by Type (2018-2024) & (Kiloton)
Table 62. Europe Parenteral Dosage Form Sales by Type (2024-2029) & (Kiloton)
Table 63. Europe Parenteral Dosage Form Revenue by Type (2018-2024) & (US$ Million)
Table 64. Europe Parenteral Dosage Form Revenue by Type (2024-2029) & (US$ Million)
Table 65. Europe Parenteral Dosage Form Sales by Application (2018-2024) & (Kiloton)
Table 66. Europe Parenteral Dosage Form Sales by Application (2024-2029) & (Kiloton)
Table 67. Europe Parenteral Dosage Form Revenue by Application (2018-2024) & (US$ Million)
Table 68. Europe Parenteral Dosage Form Revenue by Application (2024-2029) & (US$ Million)
Table 69. Europe Parenteral Dosage Form Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 70. Europe Parenteral Dosage Form Revenue by Country (2018-2024) & (US$ Million)
Table 71. Europe Parenteral Dosage Form Revenue by Country (2024-2029) & (US$ Million)
Table 72. Europe Parenteral Dosage Form Sales by Country (2018-2024) & (Kiloton)
Table 73. Europe Parenteral Dosage Form Sales by Country (2024-2029) & (Kiloton)
Table 74. China Parenteral Dosage Form Sales by Type (2018-2024) & (Kiloton)
Table 75. China Parenteral Dosage Form Sales by Type (2024-2029) & (Kiloton)
Table 76. China Parenteral Dosage Form Revenue by Type (2018-2024) & (US$ Million)
Table 77. China Parenteral Dosage Form Revenue by Type (2024-2029) & (US$ Million)
Table 78. China Parenteral Dosage Form Sales by Application (2018-2024) & (Kiloton)
Table 79. China Parenteral Dosage Form Sales by Application (2024-2029) & (Kiloton)
Table 80. China Parenteral Dosage Form Revenue by Application (2018-2024) & (US$ Million)
Table 81. China Parenteral Dosage Form Revenue by Application (2024-2029) & (US$ Million)
Table 82. Asia Parenteral Dosage Form Sales by Type (2018-2024) & (Kiloton)
Table 83. Asia Parenteral Dosage Form Sales by Type (2024-2029) & (Kiloton)
Table 84. Asia Parenteral Dosage Form Revenue by Type (2018-2024) & (US$ Million)
Table 85. Asia Parenteral Dosage Form Revenue by Type (2024-2029) & (US$ Million)
Table 86. Asia Parenteral Dosage Form Sales by Application (2018-2024) & (Kiloton)
Table 87. Asia Parenteral Dosage Form Sales by Application (2024-2029) & (Kiloton)
Table 88. Asia Parenteral Dosage Form Revenue by Application (2018-2024) & (US$ Million)
Table 89. Asia Parenteral Dosage Form Revenue by Application (2024-2029) & (US$ Million)
Table 90. Asia Parenteral Dosage Form Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 91. Asia Parenteral Dosage Form Revenue by Region (2018-2024) & (US$ Million)
Table 92. Asia Parenteral Dosage Form Revenue by Region (2024-2029) & (US$ Million)
Table 93. Asia Parenteral Dosage Form Sales by Region (2018-2024) & (Kiloton)
Table 94. Asia Parenteral Dosage Form Sales by Region (2024-2029) & (Kiloton)
Table 95. Middle East, Africa and Latin America Parenteral Dosage Form Sales by Type (2018-2024) & (Kiloton)
Table 96. Middle East, Africa and Latin America Parenteral Dosage Form Sales by Type (2024-2029) & (Kiloton)
Table 97. Middle East, Africa and Latin America Parenteral Dosage Form Revenue by Type (2018-2024) & (US$ Million)
Table 98. Middle East, Africa and Latin America Parenteral Dosage Form Revenue by Type (2024-2029) & (US$ Million)
Table 99. Middle East, Africa and Latin America Parenteral Dosage Form Sales by Application (2018-2024) & (Kiloton)
Table 100. Middle East, Africa and Latin America Parenteral Dosage Form Sales by Application (2024-2029) & (Kiloton)
Table 101. Middle East, Africa and Latin America Parenteral Dosage Form Revenue by Application (2018-2024) & (US$ Million)
Table 102. Middle East, Africa and Latin America Parenteral Dosage Form Revenue by Application (2024-2029) & (US$ Million)
Table 103. Middle East, Africa and Latin America Parenteral Dosage Form Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 104. Middle East, Africa and Latin America Parenteral Dosage Form Revenue by Country (2018-2024) & (US$ Million)
Table 105. Middle East, Africa and Latin America Parenteral Dosage Form Revenue by Country (2024-2029) & (US$ Million)
Table 106. Middle East, Africa and Latin America Parenteral Dosage Form Sales by Country (2018-2024) & (Kiloton)
Table 107. Middle East, Africa and Latin America Parenteral Dosage Form Sales by Country (2024-2029) & (Kiloton)
Table 108. Ashland Company Information
Table 109. Ashland Description and Major Businesses
Table 110. Ashland Parenteral Dosage Form Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 111. Ashland Parenteral Dosage Form Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. Ashland Recent Developments
Table 113. Tepnel Pharma Services Company Information
Table 114. Tepnel Pharma Services Description and Major Businesses
Table 115. Tepnel Pharma Services Parenteral Dosage Form Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 116. Tepnel Pharma Services Parenteral Dosage Form Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Tepnel Pharma Services Recent Developments
Table 118. Ascendia Pharmaceuticals Company Information
Table 119. Ascendia Pharmaceuticals Description and Major Businesses
Table 120. Ascendia Pharmaceuticals Parenteral Dosage Form Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 121. Ascendia Pharmaceuticals Parenteral Dosage Form Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Ascendia Pharmaceuticals Recent Developments
Table 123. Thermo Fisher Scientific Company Information
Table 124. Thermo Fisher Scientific Description and Major Businesses
Table 125. Thermo Fisher Scientific Parenteral Dosage Form Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 126. Thermo Fisher Scientific Parenteral Dosage Form Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Thermo Fisher Scientific Recent Developments
Table 128. ProJect Pharmaceutics Company Information
Table 129. ProJect Pharmaceutics Description and Major Businesses
Table 130. ProJect Pharmaceutics Parenteral Dosage Form Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 131. ProJect Pharmaceutics Parenteral Dosage Form Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. ProJect Pharmaceutics Recent Developments
Table 133. Lonza Company Information
Table 134. Lonza Description and Major Businesses
Table 135. Lonza Parenteral Dosage Form Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 136. Lonza Parenteral Dosage Form Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. Lonza Recent Developments
Table 138. BOC Sciences Company Information
Table 139. BOC Sciences Description and Major Businesses
Table 140. BOC Sciences Parenteral Dosage Form Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 141. BOC Sciences Parenteral Dosage Form Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. BOC Sciences Recent Developments
Table 143. Key Raw Materials Lists
Table 144. Raw Materials Key Suppliers Lists
Table 145. Parenteral Dosage Form Distributors List
Table 146. Parenteral Dosage Form Customers List
Table 147. Parenteral Dosage Form Market Trends
Table 148. Parenteral Dosage Form Market Drivers
Table 149. Parenteral Dosage Form Market Challenges
Table 150. Parenteral Dosage Form Market Restraints
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
List of Figures
Figure 1. Parenteral Dosage Form Product Picture
Figure 2. Global Parenteral Dosage Form Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Parenteral Dosage Form Market Share by Type in 2022 & 2029
Figure 4. Emulsions for Injection Product Picture
Figure 5. Powders for Injection Product Picture
Figure 6. Gels for Injection Product Picture
Figure 7. Global Parenteral Dosage Form Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 8. Global Parenteral Dosage Form Market Share by Application in 2022 & 2029
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Others
Figure 12. Parenteral Dosage Form Report Years Considered
Figure 13. Global Parenteral Dosage Form Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Parenteral Dosage Form Revenue 2018-2029 (US$ Million)
Figure 15. Global Parenteral Dosage Form Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 16. Global Parenteral Dosage Form Revenue Market Share by Region (2018-2029)
Figure 17. Global Parenteral Dosage Form Sales 2018-2029 ((Kiloton)
Figure 18. Global Parenteral Dosage Form Sales Market Share by Region (2018-2029)
Figure 19. US & Canada Parenteral Dosage Form Sales YoY (2018-2029) & (Kiloton)
Figure 20. US & Canada Parenteral Dosage Form Revenue YoY (2018-2029) & (US$ Million)
Figure 21. Europe Parenteral Dosage Form Sales YoY (2018-2029) & (Kiloton)
Figure 22. Europe Parenteral Dosage Form Revenue YoY (2018-2029) & (US$ Million)
Figure 23. China Parenteral Dosage Form Sales YoY (2018-2029) & (Kiloton)
Figure 24. China Parenteral Dosage Form Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Asia (excluding China) Parenteral Dosage Form Sales YoY (2018-2029) & (Kiloton)
Figure 26. Asia (excluding China) Parenteral Dosage Form Revenue YoY (2018-2029) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Parenteral Dosage Form Sales YoY (2018-2029) & (Kiloton)
Figure 28. Middle East, Africa and Latin America Parenteral Dosage Form Revenue YoY (2018-2029) & (US$ Million)
Figure 29. The Parenteral Dosage Form Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 30. The Top 5 and 10 Largest Manufacturers of Parenteral Dosage Form in the World: Market Share by Parenteral Dosage Form Revenue in 2022
Figure 31. Global Parenteral Dosage Form Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 32. Global Parenteral Dosage Form Sales Market Share by Type (2018-2029)
Figure 33. Global Parenteral Dosage Form Revenue Market Share by Type (2018-2029)
Figure 34. Global Parenteral Dosage Form Sales Market Share by Application (2018-2029)
Figure 35. Global Parenteral Dosage Form Revenue Market Share by Application (2018-2029)
Figure 36. US & Canada Parenteral Dosage Form Sales Market Share by Type (2018-2029)
Figure 37. US & Canada Parenteral Dosage Form Revenue Market Share by Type (2018-2029)
Figure 38. US & Canada Parenteral Dosage Form Sales Market Share by Application (2018-2029)
Figure 39. US & Canada Parenteral Dosage Form Revenue Market Share by Application (2018-2029)
Figure 40. US & Canada Parenteral Dosage Form Revenue Share by Country (2018-2029)
Figure 41. US & Canada Parenteral Dosage Form Sales Share by Country (2018-2029)
Figure 42. U.S. Parenteral Dosage Form Revenue (2018-2029) & (US$ Million)
Figure 43. Canada Parenteral Dosage Form Revenue (2018-2029) & (US$ Million)
Figure 44. Europe Parenteral Dosage Form Sales Market Share by Type (2018-2029)
Figure 45. Europe Parenteral Dosage Form Revenue Market Share by Type (2018-2029)
Figure 46. Europe Parenteral Dosage Form Sales Market Share by Application (2018-2029)
Figure 47. Europe Parenteral Dosage Form Revenue Market Share by Application (2018-2029)
Figure 48. Europe Parenteral Dosage Form Revenue Share by Country (2018-2029)
Figure 49. Europe Parenteral Dosage Form Sales Share by Country (2018-2029)
Figure 50. Germany Parenteral Dosage Form Revenue (2018-2029) & (US$ Million)
Figure 51. France Parenteral Dosage Form Revenue (2018-2029) & (US$ Million)
Figure 52. U.K. Parenteral Dosage Form Revenue (2018-2029) & (US$ Million)
Figure 53. Italy Parenteral Dosage Form Revenue (2018-2029) & (US$ Million)
Figure 54. Russia Parenteral Dosage Form Revenue (2018-2029) & (US$ Million)
Figure 55. China Parenteral Dosage Form Sales Market Share by Type (2018-2029)
Figure 56. China Parenteral Dosage Form Revenue Market Share by Type (2018-2029)
Figure 57. China Parenteral Dosage Form Sales Market Share by Application (2018-2029)
Figure 58. China Parenteral Dosage Form Revenue Market Share by Application (2018-2029)
Figure 59. Asia Parenteral Dosage Form Sales Market Share by Type (2018-2029)
Figure 60. Asia Parenteral Dosage Form Revenue Market Share by Type (2018-2029)
Figure 61. Asia Parenteral Dosage Form Sales Market Share by Application (2018-2029)
Figure 62. Asia Parenteral Dosage Form Revenue Market Share by Application (2018-2029)
Figure 63. Asia Parenteral Dosage Form Revenue Share by Region (2018-2029)
Figure 64. Asia Parenteral Dosage Form Sales Share by Region (2018-2029)
Figure 65. Japan Parenteral Dosage Form Revenue (2018-2029) & (US$ Million)
Figure 66. South Korea Parenteral Dosage Form Revenue (2018-2029) & (US$ Million)
Figure 67. China Taiwan Parenteral Dosage Form Revenue (2018-2029) & (US$ Million)
Figure 68. Southeast Asia Parenteral Dosage Form Revenue (2018-2029) & (US$ Million)
Figure 69. India Parenteral Dosage Form Revenue (2018-2029) & (US$ Million)
Figure 70. Middle East, Africa and Latin America Parenteral Dosage Form Sales Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Parenteral Dosage Form Revenue Market Share by Type (2018-2029)
Figure 72. Middle East, Africa and Latin America Parenteral Dosage Form Sales Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Parenteral Dosage Form Revenue Market Share by Application (2018-2029)
Figure 74. Middle East, Africa and Latin America Parenteral Dosage Form Revenue Share by Country (2018-2029)
Figure 75. Middle East, Africa and Latin America Parenteral Dosage Form Sales Share by Country (2018-2029)
Figure 76. Brazil Parenteral Dosage Form Revenue (2018-2029) & (US$ Million)
Figure 77. Mexico Parenteral Dosage Form Revenue (2018-2029) & (US$ Million)
Figure 78. Turkey Parenteral Dosage Form Revenue (2018-2029) & (US$ Million)
Figure 79. Israel Parenteral Dosage Form Revenue (2018-2029) & (US$ Million)
Figure 80. GCC Countries Parenteral Dosage Form Revenue (2018-2029) & (US$ Million)
Figure 81. Parenteral Dosage Form Value Chain
Figure 82. Parenteral Dosage Form Production Process
Figure 83. Channels of Distribution
Figure 84. Distributors Profiles
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries